Shilin Xu
University of Michigan
H-index: 11
North America-United States
Top articles of Shilin Xu
Discovery of Pyrido[2,3-d]pyrimidin-7-one Derivatives as Highly Potent and Efficacious Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Inhibitors …
Journal of Medicinal Chemistry
2024/2/22
Discovery of a potent and selective covalent threonine tyrosine kinase (TTK) inhibitor
Bioorganic Chemistry
2024/2/1
Discovery of a PROTAC degrader for METTL3-METTL14 complex
Cell Chemical Biology
2024/1/18
Development of a potent benzonitrile-based inhibitor of glutaminyl-peptide cyclotransferase-like protein (QPCTL) with antitumor efficacy
Signal Transduction and Targeted Therapy
2023/12/15
Discovery and Structural Optimization of Covalent ZAP-70 Kinase Inhibitors against Psoriasis
Journal of Medicinal Chemistry
2023/8/18
Discovery of 7H-Pyrrolo [2, 3-d] pyrimidine Derivatives as potent hematopoietic progenitor kinase 1 (HPK1) inhibitors
European Journal of Medicinal Chemistry
2023/6/5
Qi An
H-Index: 6
Shilin Xu
H-Index: 7
Discovery of a potent and selective proteolysis targeting chimera (PROTAC) degrader of NSD3 histone methyltransferase
European Journal of Medicinal Chemistry
2022/9/5
Structure-based discovery of a series of NSD2-PWWP1 inhibitors
Journal of Medicinal Chemistry
2022/6/15
Luteolin promotes macrophage-mediated phagocytosis by inhibiting CD47 pyroglutamation
Translational Oncology
2021/8/1
Discovery of a potent, selective, and covalent ZAP-70 kinase inhibitor
European Journal of Medicinal Chemistry
2021/7/5
Discovery of M-1121 as an orally active covalent inhibitor of menin-MLL interaction capable of achieving complete and long-lasting tumor regression
Journal of medicinal chemistry
2021/7/1
Piperidines as covalent menin inhibitors
2021/6/29
Piperidine compounds as covalent menin inhibitors
2021/4/22
Follicular lymphoma–associated BTK mutations are Inactivating resulting in augmented AKT activation
Clinical Cancer Research
2021/4/15
Small molecule menin inhibitors
2021/11/18
Piperidines as menin inhibitors
2021/9/8
Discovery of M-808 as a Highly Potent, Covalent, Small-Molecule Inhibitor of the Menin–MLL Interaction with Strong In Vivo Antitumor Activity
Journal of medicinal chemistry
2020/4/27